Published date: 5 March 2025
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Pharmacy services - 85149000
Location of contract
NW1 2PB
Value of contract
£81,600 to £816,000
Procurement reference
CF-2881000D0O000000rwimUAA
Published date
5 March 2025
Closing date
26 March 2025
Closing time
12pm
Contract start date
3 November 2025
Contract end date
2 November 2027
Contract type
Service contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
The service requirements for the direct supply and administration of Lecanemab (Leqembi) in a patient's home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The service is being offered by UCLH private Healthcare and will be for private patients only. The requirement is for a private homecare provider situated in the UK to provide this service.
More information
Additional text
-
To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.
Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:
Phone: 0800 9956035
E-mail: support-health@atamis.co.uk
About the buyer
Contact name
Aaron Monaghan
Address
179a Tottenham Court Road
London
NW1 2PB
GB
Share this notice
Closing: 26 March 2025, 12pm
All content is available under the
